CLINICAL_TRIALS
trial_result
· 2016-05-30
Clinical Trial Update: Oral Testosterone for the Treatment of Hypogonadism in Males [Phase 2]
Summary
A Phase 2 trial evaluating oral testosterone for hypogonadism in males has completed, with results posted on May 30, 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: TesoRx Pharma, LLC | Conditions: Hypogonadism | Phase 2 | Status: COMPLETED | Results posted: 2016-05-30